BBIO icon

BridgeBio Pharma

250 hedge funds and large institutions have $4.43B invested in BridgeBio Pharma in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 106 increasing their positions, 73 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

0.38% more ownership

Funds ownership: 93.11%93.49% (+0.38%)

14% less funds holding in top 10

Funds holding in top 10: 1412 (-2)

18% less capital invested

Capital invested by funds: $5.42B → $4.43B (-$989M)

Holders
250
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
12
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$306M
Puts
$85.9M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
126
$1.13M
127
$1.12M
128
$990K
129
$987K
130
$936K
131
$925K
132
$905K
133
$904K
134
$896K
135
$881K
136
$855K
137
$852K
138
$828K
139
$807K
140
$782K
141
$781K
142
$765K
143
$738K
144
$737K
145
$714K
146
$700K
147
$688K
148
$676K
149
$675K
150
$635K